Cirrhotic cardiomyopathy

Cirrhotic cardiomyopathy is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1052540676
P356DOI10.1186/1750-1172-2-15
P932PMC publication ID1847677
P698PubMed publication ID17389039

P2093author name stringSoon Koo Baik
Samuel S Lee
Tamer R Fouad
P2860cites workCannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscleQ31136248
Cardiopulmonary dysfunction in cirrhosis.Q33672187
Cirrhotic cardiomyopathy and liver transplantationQ33983997
Coronary artery disease and liver transplantation: the state of the art.Q33984005
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidityQ34275352
Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver diseaseQ34467402
Nitric oxide and renal and cardiac dysfunction in cirrhosisQ34521737
Hemodynamic correlates of outcome in patients undergoing orthotopic liver transplantation. Evidence for early postoperative myocardial depressionQ72389091
Is there a cirrhotic cardiomyopathy?Q73234040
Cardiac muscarinic receptor function in rats with cirrhotic cardiomyopathyQ73420900
Potassium currents in atrial and ventricular myocytes from a rat model of cirrhosisQ73644914
Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantationQ73744089
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascitesQ73856981
Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factorsQ74027068
Post-liver transplantation myocardial dysfunctionQ77182453
Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS)Q77540935
Dyssynchronous electrical and mechanical systole in patients with cirrhosisQ77908527
Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosisQ78176757
Cirrhotic cardiomyopathyQ78520606
Cardiac dysfunction in spontaneous bacterial peritonitis: A manifestation of cirrhotic cardiomyopathy?Q79209018
Cardiac alterations in cirrhosis: reversibility after liver transplantationQ81223866
The cardiac output at rest in Laennec's cirrhosisQ35258043
Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shuntQ35355011
The cardiac response to exercise in cirrhosisQ35364575
Ventricular function in noncardiacs with alcoholic fatty liver: role of ethanol in the production of cardiomyopathyQ35568074
Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.Q35596013
Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shuntQ35953809
Cardiac morbidity and mortality related to orthotopic liver transplantation.Q35959916
Cardiac electrophysiological abnormalities in patients with cirrhosisQ36410682
Therapy insight: Cirrhotic cardiomyopathyQ36495176
Cardiovascular determinants of survival in cirrhosisQ36829265
Liver transplantation (2).Q38699980
Cardiac abnormalities in liver cirrhosisQ38746072
Cardiac hemodynamics in alcoholic patients with chronic liver disease and a presystolic gallopQ40473385
Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosisQ40536256
The hemodynamic response to exercise in patients with Laennec's cirrhosisQ40993985
Cirrhotic cardiomyopathy: getting to the heart of the matterQ41021596
Alterations in isoprenaline sensitivity in patients with cirrhosis: evidence of abnormality of the sympathetic nervous activityQ41976384
Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts.Q42003359
Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated ratsQ42200119
Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in ratsQ42516553
Cirrhotic cardiomyopathy: an endocannabinoid connection?Q43261370
Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat.Q43512658
Altered cellular calcium regulatory systems in a rat model of cirrhotic cardiomyopathyQ43777318
Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosisQ43785988
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosisQ44231605
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.Q44632315
Systemic hemodynamic and cardiac function changes in patients undergoing orthotopic liver transplantationQ44972397
Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosisQ46447287
Circulatory function and hepatorenal syndrome in cirrhosis.Q46565582
Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarctionQ48298813
Plasma levels of brain natriuretic peptide in patients with cirrhosisQ48459198
Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?Q48703428
Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophyQ48853320
Effects of amrinone on ischaemia-reperfusion injury in cirrhotic patients undergoing hepatectomy: a comparative study with prostaglandin E1.Q53762740
Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.Q54103967
Mechanism of nitric oxide-induced vasodilatation: refilling of intracellular stores by sarcoplasmic reticulum Ca2+ ATPase and inhibition of store-operated Ca2+ influx.Q54106152
Effect of volume expansion on hemodynamics, capillary permeability and renal function in conscious, cirrhotic rats.Q54434474
Impaired left ventricular function in alcoholic cirrhosis with ascites. Ineffectiveness of ouabain.Q54639652
Elevated circulating cardiac troponin I in patients with cirrhosis.Q54645715
QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shuntQ57004208
Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct–ligated ratsQ58308584
What happens to cirrhotic cardiomyopathy after liver transplantation?Q58308638
Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosisQ59654600
Atrial natriuretic factor in cirrhosis with ascites: Plasma levels, cardiac release and splanchnic extractionQ61577424
Membrane fluidity and transport properties in epitheliaQ67507471
Limited cardiac preload reserve in conscious cirrhotic ratsQ67692995
Fatal torsade de pointes occurring in a patient receiving intravenous vasopressin and nitroglycerinQ67907785
Desensitization of myocardial beta-adrenergic receptors in cirrhotic ratsQ68477905
Echocardiographic findings before and after liver transplantationQ69891360
Cardiac performance in patients with asymptomatic alcoholic cirrhosis of the liverQ70635876
Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantationQ71023569
Prolongation of the QTc-interval reflects the severity of autonomic neuropathy in primary biliary cirrhosis and in other non-alcoholic liver diseasesQ71547130
Left ventricular diastolic function in liver cirrhosisQ71596534
Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide relatedQ71603519
Hemodynamic effects of dobutamine in patients with alcoholic cirrhosisQ71761975
Membrane physical properties determine cardiac beta-adrenergic receptor function in cirrhotic ratsQ72101412
Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalanceQ72198313
High-output congestive heart failure following transjugular intrahepatic portal-systemic shuntingQ72236984
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectliver cirrhosisQ147778
cardiomyopathyQ847583
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)15
P577publication date2007-03-27
P1433published inOrphanet Journal of Rare DiseasesQ15756117
P1476titleCirrhotic cardiomyopathy
P478volume2

Reverse relations

cites work (P2860)
Q37892712A perspective on cirrhotic cardiomyopathy
Q35308671Arrhythmia risk in liver cirrhosis.
Q92982272Association of Cirrhosis and Cardiomyopathy
Q50972269Cardiac abnormalities in cirrhotic children: pre- and post-liver transplantation.
Q41818548Cardiac dysfunction in liver cirrhosis: A tissue Doppler imaging study from Egypt
Q38724506Cardiac manifestations in alcoholic liver disease
Q38267664Cardiohepatic syndrome
Q53058927Cardiomyocyte apoptosis contributes to pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated mice.
Q27010592Cardiovascular dysfunction in patients with liver cirrhosis
Q41650209Cirrhotic Cardiomyopathy: Another Case of a Successful Approach to Treatment of Hepatorenal Syndrome
Q26778048Cirrhotic cardiomyopathy
Q40029009Cirrhotic cardiomyopathy: Isn't stress evaluation always required for the diagnosis?
Q38268611Cirrhotic cardiomyopathy: a cardiologist's perspective
Q38249191Cirrhotic cardiomyopathy: review of pathophysiology and treatment
Q64245031Cirrhotic cardiomyopathy: the liver affects the heart
Q35833011Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis
Q36662684Evaluation of cardiac functions of cirrhotic children using serum brain natriuretic peptide and tissue Doppler imaging
Q37854328Hemodynamic alterations in cirrhosis and portal hypertension
Q36721334High Flow-Mediated Vasodilatation Predicts Pulmonary Edema in Liver Transplant Patients.
Q51823738Liver and systemic hemodynamics in children with cirrhosis: Impact on the surgical management in pediatric living donor liver transplantation.
Q38249875Management of Complications of End-Stage Liver Disease in the Intensive Care Unit.
Q47912085Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations
Q83260371Postreperfusion syndrome during orthotopic liver transplantation: a single-center experience
Q89976306Relationship between Heart Disease and Liver Disease: A Two-Way Street
Q35636735Reversible Cardiomyopathies
Q37811399Reversible Cardiomyopathies—A Review
Q27011341Role of cardiovascular intervention as a bridge to liver transplantation
Q40511957Systemic vascular resistance and fluid status in patients with decompensated liver cirrhosis with or without functional renal failure in Egypt
Q33758733The Correlation between Echocardiographic Findings and QT Interval in Cirrhotic Patients

Search more.